Stockholders' Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 26, 2022 |
Mar. 15, 2022 |
Feb. 14, 2022 |
Dec. 22, 2021 |
Dec. 02, 2021 |
Aug. 19, 2021 |
May 18, 2021 |
Oct. 01, 2020 |
Sep. 02, 2020 |
Aug. 03, 2020 |
Jul. 31, 2020 |
Jul. 28, 2020 |
Jun. 08, 2020 |
Apr. 06, 2020 |
Jan. 09, 2020 |
Dec. 21, 2021 |
Sep. 29, 2021 |
May 18, 2021 |
Sep. 25, 2020 |
Jul. 31, 2020 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Preferred stock, shares authorized | 25,000,000 | 25,000,000 | 25,000,000 | 25,000,000 | ||||||||||||||||||||||
| Preferred stock, par value per share (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
| Preferred stock, shares outstanding | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
| Common stock, shares authorized | 18,750,000 | 18,750,000 | 18,750,000 | 18,750,000 | ||||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
| Common stock, shares outstanding | 10,132,047 | 10,207,212 | 10,207,212 | 10,207,212 | ||||||||||||||||||||||
| Exercised | 75,000 | |||||||||||||||||||||||||
| Additional shares | 49,444 | 1,325,000 | ||||||||||||||||||||||||
| Shares available for grant | 256,014 | 256,014 | 318,514 | |||||||||||||||||||||||
| Granted purchased shares | 100,000 | 383,125 | ||||||||||||||||||||||||
| Gross proceeds from sale of equity (in Dollars) | $ 5,000,000 | $ 17,250,000 | ||||||||||||||||||||||||
| Restricted stock award net of forfeitures (in Dollars) | $ 295,750 | |||||||||||||||||||||||||
| Class of warrant or right, outstanding | 4,813,836 | 4,813,836 | 3,036,185 | |||||||||||||||||||||||
| Exercise price of warrants or rights (in Dollars per share) | $ 20 | |||||||||||||||||||||||||
| Warrants exercisable term | 5 years | |||||||||||||||||||||||||
| Warrants liabilities (in Dollars) | $ 1,792,000 | $ (278,000) | $ 3,622,000 | (278,000) | $ 1,387,000 | |||||||||||||||||||||
| Salary expenses (in Dollars) | $ 30,000 | 902,106 | 683,197 | 1,817,746 | 1,567,238 | 2,887,309 | 915,210 | |||||||||||||||||||
| Professional fees (in Dollars) | 873,865 | 455,552 | 1,417,905 | 984,625 | $ 2,269,756 | 1,153,731 | ||||||||||||||||||||
| Warrants to purchase common shares | 749,984 | |||||||||||||||||||||||||
| Share based payment arrangement, expense (in Dollars) | 676,242 | $ 194,657 | 1,392,674 | $ 562,375 | ||||||||||||||||||||||
| Unrecognized compensation cost, non vested (in Dollars) | $ 2,154,935 | $ 2,154,935 | ||||||||||||||||||||||||
| Unrecognized compensation, weighted average period | 1 year 10 months 6 days | |||||||||||||||||||||||||
| Common stock, shares issued | 10,132,047 | |||||||||||||||||||||||||
| Stock issued during period, shares, new issues | 1,150,000 | 5,000 | 40,000 | 31,250 | ||||||||||||||||||||||
| Stock issued during period, value, new issues (in Dollars) | $ 20,200 | $ 161,600 | $ 126,250 | 6,275,164 | ||||||||||||||||||||||
| Exercise of stock options | 1,250 | |||||||||||||||||||||||||
| Stock issued during period services, value (in Dollars) | 237,500 | |||||||||||||||||||||||||
| Stock issued during period, value, conversion of convertible securities (in Dollars) | 261,453 | |||||||||||||||||||||||||
| Stock issued during period acquisition, value (in Dollars) | $ 7,774,000 | $ 12,500,000 | ||||||||||||||||||||||||
| Secured Borrowings, Gross, Difference, Amount (in Dollars) | $ 1,237,760 | |||||||||||||||||||||||||
| Shares of common stock | 5,000 | 247,552 | ||||||||||||||||||||||||
| Net amount (in Dollars) | $ 1,116,566 | |||||||||||||||||||||||||
| Common stock price (in Dollars per share) | $ 5 | |||||||||||||||||||||||||
| Warrant share | 9,091 | |||||||||||||||||||||||||
| Exercise price (in Dollars per share) | $ 5.5 | |||||||||||||||||||||||||
| Stock incentive plan description | the Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (“SIP”). The SIP incorporates stock options issued prior to May 18, 2021. The SIP authorized 1,325,000 options for issuance. As of December 31, 2021, there remains 412,264 options available for issuance. | |||||||||||||||||||||||||
| Granted shares | 383,125 | 335,000 | ||||||||||||||||||||||||
| Aggregate shares | 261,387 | |||||||||||||||||||||||||
| strike price (in Dollars per share) | $ 9 | |||||||||||||||||||||||||
| Warrant term | 5 years | |||||||||||||||||||||||||
| Exchange agreements description | On December 21, 2021, pursuant to the December 2021 Exchange Agreements (Note 6) all previously issued Original Class C warrants were replaced with an aggregate of 416,011 pro-rata New Class C warrants with an exercise price of $9.00 per share (unchanged) and a five-year life measured from the date of the December 2021 Exchange Agreements. The decrease in the Unit price also resulted in additional number of New Class C Warrants being issued in exchange for the Original Class C Warrants due to the 200% warrant coverage provided for in the Unit Purchase Agreement. On December 21, 2021, pursuant to the December 2021 Unit Purchase Agreement the Company issued additional 1,714,286 New Class C warrants with an exercise price of $9.00 per share and a term of five years. The detachable warrants issued were accounted for as an equity instrument and were ascribed an aggregate fair market value of $4,447,982 using the residual fair value allocation method. | |||||||||||||||||||||||||
| Somah acquisition description | On July 31, 2020, the Company completed the Somah Acquisition (Note 2) whereas 2,500,000 shares of common stock and 749,984 warrants were issued. The warrants have a strike price of $20.00 per share and a term of five years. The valuation of the warrants granted was completed during the year ended December 31, 2021, and the fair market value was determined to be $1.60 per share or $1,200,000. | |||||||||||||||||||||||||
| Warrant Purchase | 28,001 | |||||||||||||||||||||||||
| Fair market value description | The fair market value was determined to be $3.625 per share or $152,249 and $101,500, respectively, or $253,749, collectively. | |||||||||||||||||||||||||
| Stock-based compensation description | During the year ended December 31, 2021, the Company recorded $865,111 in non-cash share-based compensation (2020 - $1,833,292). Additionally, the Company recognized $33,333 of stock-based compensation on restricted common stock in the year ended December 31, 2021. | |||||||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Common stock, shares outstanding | 8,982,212 | 8,982,212 | ||||||||||||||||||||||||
| Common stock, shares issued | 10,132,212 | |||||||||||||||||||||||||
| Stock issued during period, value, new issues (in Dollars) | $ 1,400 | |||||||||||||||||||||||||
| Stock issued during period, shares, services | 53,750 | |||||||||||||||||||||||||
| Stock issued during period services, value (in Dollars) | $ 54 | |||||||||||||||||||||||||
| Stock issued during period, shares, conversion of convertible securities | 63,514 | |||||||||||||||||||||||||
| Stock issued during period, value, conversion of convertible securities (in Dollars) | $ 64 | |||||||||||||||||||||||||
| Issuance of common stock for acquisition, shares | 1,150,000 | 2,500,000 | ||||||||||||||||||||||||
| Stock issued during period acquisition, value (in Dollars) | $ 1,150 | $ 2,500 | ||||||||||||||||||||||||
| Private placement description | ●On August 3, 2020, the Company completed an initial closing of a private placement pursuant to which the Company sold and issued an aggregate of 1,152,496 shares of its common stock at a purchase price of $5.00 per share. In consideration for services rendered as the placement agent in the private placement, the Company paid Univest Securities LLC cash commissions totaling $460,999, or 8% of the gross proceeds of the private placement closing, a 1% non-accountable expense allowance totaling $57,625, and the $31,250 balance (of a total of $37,500) due to the placement agent in advisory fees. Additionally, the Company issued to the placement agent a five-year warrant to purchase an aggregate of 57,375 shares of the Company’s Common Stock at an exercise price of $5.50 per share. The warrant, for which the placement agent paid the Company $100, may be exercised on a cashless basis. | |||||||||||||||||||||||||
| Restricted shares | 10,000 | |||||||||||||||||||||||||
| strike price (in Dollars per share) | $ 5.5 | |||||||||||||||||||||||||
| Warrant term | 4 years 8 months 26 days | |||||||||||||||||||||||||
| Fair value amount (in Dollars) | $ 368,287 | |||||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Shares of common stock | 57,499 | |||||||||||||||||||||||||
| strike price (in Dollars per share) | $ 5.56 | |||||||||||||||||||||||||
| Warrant Purchase | 42,002 | |||||||||||||||||||||||||
| Common stock conversion debt [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Stock issued during period, shares, conversion of convertible securities | 16,014 | |||||||||||||||||||||||||
| Stock issued during period, value, conversion of convertible securities (in Dollars) | $ 59,453 | |||||||||||||||||||||||||
| Unit Purchase Agreements Warrants [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Unit purchase agreements warrants description | Pursuant to the May Unit Purchase Agreement (Note 6) the Company issued: (i) Class A Warrants for the purchase an aggregate of 117,495 shares of common stock, with a strike price of $12.52 per share and a term of five years, and (ii) Class B Warrants for the purchase an aggregate of 117,495 shares of common stock with a strike price of $20.00 per share and a term of five years. | |||||||||||||||||||||||||
| Restricted Stock Units (RSUs) [Member] | Common Stock [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Shares of common stock | 87,500 | |||||||||||||||||||||||||
| Compensation cost (in Dollars) | ||||||||||||||||||||||||||
| Soma acquisition [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Issuance of common stock for acquisition, shares | 2,500,000 | |||||||||||||||||||||||||
| Stock issued during period acquisition, value (in Dollars) | $ 12,500,000 | |||||||||||||||||||||||||
| Univest Securities [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Exercise price of warrants or rights (in Dollars per share) | $ 7 | |||||||||||||||||||||||||
| Warrants exercisable term | 5 years | |||||||||||||||||||||||||
| Warrants liabilities (in Dollars) | $ 1,281,854 | |||||||||||||||||||||||||
| Warrants issued (in Dollars) | $ 57,840 | |||||||||||||||||||||||||
| Salary expenses (in Dollars) | 769,113 | |||||||||||||||||||||||||
| Professional fees (in Dollars) | 512,471 | |||||||||||||||||||||||||
| Bradely Richmond [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Exercised | 75,000 | |||||||||||||||||||||||||
| Warrants to purchase | 75,000 | |||||||||||||||||||||||||
| Exercise price of warrants or rights (in Dollars per share) | $ 0.04 | |||||||||||||||||||||||||
| Warrants liabilities (in Dollars) | $ 568,677 | |||||||||||||||||||||||||
| Warrants issued (in Dollars) | $ 86,760 | |||||||||||||||||||||||||
| Bradely Richmond [Member] | Common Stock [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Warrants to purchase | 75,000 | |||||||||||||||||||||||||
| Bradely Richmond [Member] | Warrant [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Warrants to purchase | 144,600 | |||||||||||||||||||||||||
| Consultant [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Stock issued during period, shares, services | 5,000 | 3,750 | ||||||||||||||||||||||||
| Stock issued during period services, value (in Dollars) | $ 25,000 | $ 15,150 | ||||||||||||||||||||||||
| Unit Purchase Agreement [Member] | Class C Warrants [Member] | ||||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Exercise price of warrants or rights (in Dollars per share) | $ 9 | $ 9 | ||||||||||||||||||||||||
| Warrants exercisable term | 5 years | |||||||||||||||||||||||||
| Warrants to purchase common shares | 1,661,458 | 1,661,458 | ||||||||||||||||||||||||